Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Anika Therapeutics (ANIK) over the last 7 years, with Q3 2025 value amounting to $495000.0.

  • Anika Therapeutics' Amortizatization of Intangibles fell 1552.9% to $495000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3866.55%. This contributed to the annual value of $2.2 million for FY2024, which is 7237.57% down from last year.
  • Anika Therapeutics' Amortizatization of Intangibles amounted to $495000.0 in Q3 2025, which was down 1552.9% from $490000.0 recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Amortizatization of Intangibles peaked at $2.0 million during Q1 2021, and registered a low of $410000.0 during Q2 2024.
  • Over the past 5 years, Anika Therapeutics' median Amortizatization of Intangibles value was $1.9 million (recorded in 2022), while the average stood at $1.4 million.
  • As far as peak fluctuations go, Anika Therapeutics' Amortizatization of Intangibles skyrocketed by 47735.29% in 2021, and later plummeted by 7892.03% in 2024.
  • Quarter analysis of 5 years shows Anika Therapeutics' Amortizatization of Intangibles stood at $2.0 million in 2021, then dropped by 0.31% to $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then plummeted by 69.73% to $589000.0 in 2024, then decreased by 15.96% to $495000.0 in 2025.
  • Its last three reported values are $495000.0 in Q3 2025, $490000.0 for Q2 2025, and $577000.0 during Q1 2025.